ANDAORAL-28TABLET
Approved
Mar 2019
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
3/8 — Basic
KEMEYA (drospirenone; ethinyl estradiol) by Fosun Pharma is ovulation. Approved for pregnancy. First approved in 2019.
Drug data last refreshed 18h ago
Mechanism of Action
ovulation.
Indications (1)
Company
Worked on KEMEYA at Fosun Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.